ASCO: Add - On Ibrutinib Slows Mantle - Cell Lymphoma in Older Adults

Addition of ibrutinib to chemoimmunotherapy prolongs progression - free survival in older patients with untreated mantle - cell lymphoma
Source: The Doctors Lounge - Oncology - Category: Cancer & Oncology Tags: Oncology, Pharmacy, Conference News, Source Type: news